Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rosuvastatin and calcitriol on voice problems after total thyroidectomy
IRCT20230711058741N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rosuvastatin and calcitriol in dysphonia, sponsored by Shiraz University of Medical Sciences. Started Mar 2024; status: completed.
02
Drugs
rosuvastatincalcitriol
03
Conditions
dysphonia
Beyond the preview
Go deeper on IRCT20230711058741N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230711058741N1.